Trademark: 90801633
Word
NEOGENOMICS EUROPE
Status
Dead
Status Code
606
Status Date
Monday, March 18, 2024
Serial Number
90801633
Mark Type
4000
Filing Date
Tuesday, June 29, 2021
Published for Opposition
Tuesday, December 20, 2022
Abandoned Date
Monday, March 18, 2024

Trademark Owner History
NeoGenomics Laboratories, Inc. - Owner At Publication

Classifications
5 Pre-packaged medical tests kits to aid in the diagnosis of disease or cancer, namely, kits primarily composed of clinical medical reagents and assays for use in disease testing for clinical medical laboratory use
44 Medical diagnostic testing services in the field of human disease and human medical conditions; medical testing for diagnostic or treatment purposes; providing medical information to others in the field of human disease, human medical conditions, medical diagnostic testing services and medical testing for diagnostic or treatment purposes; providing an Internet website portal featuring medical information in the field of human disease, and human medical conditions, medical diagnostic testing services, medical testing for diagnostic or treatment purposes; providing cloud-based medical information to others in the field of human disease, human medical conditions, medical diagnostic testing services, and medical testing for diagnostic or treatment purposes; medical testing for the detection of cancer; medical testing for the detection of genetic information pertaining to human disease; medical diagnostic testing to aid in diagnosis, prognosis and therapy selection; oncology reference laboratory services
10 Pre-packaged medical tests kits to aid in the diagnosis of disease or cancer, namely, kits primarily composed of DNA probes for use in disease testing for clinical medical laboratory use
42 Medical research; genetic mapping for scientific purposes, namely, gene sequencing; genetic testing and sequencing for scientific research purposes; molecular sequencing for scientific research purposes; cancer study and analysis, cytometry, cytogenetics, cell analysis, cell preservation, clinical study and testing of cells all being for scientific purposes; clinical study and testing of cells for scientific or research purposes; medical and scientific research information in the field of gene sequencing, molecular sequencing, cancer study and analysis, clinical study and testing of cells; medical and scientific research in the field of gene sequencing, molecular sequencing, cancer study and analysis, cytometry, cytogenetics, cell analysis, cell preservation, clinical study and testing of cells, and cancer; providing scientific information to others in the fields of oncology, pathology and gene sequencing, molecular sequencing, cancer study and analysis, clinical study and testing of cells scientific testing and research services and clinical scientific testing; providing an internet website portal featuring gene sequencing, molecular sequencing, cancer study and analysis, clinical study and testing of cells for scientific purposes; scientific and medical research information in the fields of scientific testing and research services, medical research services, and clinical scientific testing; providing cloud-based scientific and medical research information in the nature of providing temporary use of non-downloadable cloud based software for providing information to others in the field of scientific testing and research services, medical research services, and clinical scientific testing; providing temporary use of online non-downloadable software for analysis, research, and review of information pertaining to medical, scientific, genetic, testing and analysis, and information and pertaining to such testing and analysis; software as a service (SAAS) services featuring software for analysis of medical test results; non-downloadable computer software for analysis, research, and review of information pertaining to medical, scientific, genetic, testing and analysis, and information pertaining to testing and analysis; providing medical research and scientific research information in the field of oncology; scientific testing and research services in the field of human disease and human medical conditions; providing medical research services in the field of human disease and human medical conditions; providing clinical scientific testing services and medical research and testing for research purposes in the field of human disease and human medical conditions; clinical laboratory research services, oncology reference laboratory services for research and scientific purposes, providing medical research information and interactive scientific research information to others in the fields of medical tests, medical testing, medical research, pathology, diagnostic testing, oncology testing and human disease and medical conditions; providing cloud-based information in the nature of providing temporary use of non-downloadable cloud based software for providing information to others to others in the field of scientific testing and research, medical research, and clinical scientific testing; providing online non-downloadable Internet-based software for medical testing and analysis of medical test results; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; medical and scientific research, namely, conducting clinical trials for others; conducting research and clinical trials for others relating to medical devices and pharmaceuticals; software as a service (SAAS) services featuring software for use in nucleic acid and protein assay analysis and for quality control, clinical decision support, validation, interpretation, reporting, data management, integration with medical records, physician portals, laboratory networking, professional healthcare and trial matching services all related to genomic analysis and molecular analysis; providing temporary use of cloud-based non-downloadable computer software providing medical information to others in the field of human disease, human medical conditions, medical diagnostic testing services, and medical testing for diagnostic or treatment purposes
"EUROPE"

Trademark Events
Mar 18, 2024
Abandonment Notice E-Mailed - No Use Statement Filed
Mar 18, 2024
Abandonment - No Use Statement Filed
Aug 12, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 10, 2023
Sou Extension 1 Granted
Aug 10, 2023
Sou Extension 1 Filed
Aug 10, 2023
Sou Teas Extension Received
Feb 14, 2023
Noa E-Mailed - Sou Required From Applicant
Feb 1, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Feb 1, 2023
Teas Change Of Correspondence Received
Feb 1, 2023
Teas Change Of Owner Address Received
Dec 20, 2022
Official Gazette Publication Confirmation E-Mailed
Dec 20, 2022
Published For Opposition
Nov 30, 2022
Notification Of Notice Of Publication E-Mailed
Nov 16, 2022
Approved For Pub - Principal Register
Sep 28, 2022
Teas/Email Correspondence Entered
Sep 27, 2022
Correspondence Received In Law Office
Sep 27, 2022
Teas Response To Office Action Received
Jun 13, 2022
Teas Change Of Correspondence Received
Jun 13, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 13, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 28, 2022
Notification Of Non-Final Action E-Mailed
Mar 28, 2022
Non-Final Action E-Mailed
Mar 28, 2022
Non-Final Action Written
Mar 20, 2022
Assigned To Examiner
Sep 11, 2021
New Application Office Supplied Data Entered
Jul 2, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24